FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is application of a 1-aminoalkyltcyclohexane derivative specified in neramexane or its pharmaceutically acceptable salt for preparing a drug for preventing and/or treating hearing loss, except for drug-induced hearing loss, application thereof for preventing and/or treating hearing loss, except for drug-induced hearing loss and a pharmaceutical composition for the same application.
EFFECT: auditory threshold extension after 4 months of the therapy with neramexane 50 mg a day is shown.
27 cl, 1 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTERVAL THERAPY FOR TREATING TINNITUS | 2008 |
|
RU2446794C2 |
| 1-AMINOALKYLCYCLOHEXANE DERIVATIVES FOR TREATING COCHLEAR TINNITUS | 2008 |
|
RU2438658C2 |
| NERAMEXANE TITRATION KIT AND USING IT IN TREATING INTERNAL EAR DISORDERS | 2008 |
|
RU2459618C2 |
| 1-AMINOALKYLCYCLOHEXANE DERIVATIVES FOR TREATMENT OF INFLAMMATORY SKIN DISEASES | 2009 |
|
RU2481828C2 |
| DERIVATIVES OF 1-AMINO-ALKYLCYCLOHEXANE FOR TREATMENT OF DISEASES, MEDIATED BY MAST CELLS | 2009 |
|
RU2484813C2 |
| NEW COMBINATIONS OF NERAMEXANE FOR TREATING NEURODEGENERATIVE DISORDERS | 2008 |
|
RU2432161C1 |
| MATRIX TABLET WITH MODIFIED NERAMEXANE RELEASE | 2006 |
|
RU2422135C2 |
| METHOD FOR RELIEVING ALCOHOL CONSUMPTION SYMPTOMS | 2008 |
|
RU2526157C2 |
| SYNTHESIS OF 1-AMINO-1,3,3,5,5-PENTAMETHYLCYCLOHEXANE MESYLATE | 2010 |
|
RU2513090C2 |
| THERAPY OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY | 2005 |
|
RU2380094C2 |
